CRISPR Technology Market (By Types- gRNA, Proteins, Vectors, Library, Designing Tools, Control Kits, Plasmids and Others. By Application- Agricultural Biotech, Biological Research, Industrial Biotech and Drugs and Therapeutic Discovery and By Regions)– Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2018 – 2026

The CRISPR technology market was valued at USD 487.80 Million in 2018 and is expected to reach USD 3.239 Billion by 2026 growing at a high Compound annual growth rate (CAGR) of 26.70% between 2018 and 2026. The increasing purchasing power of the global population is expected to boost the demand for improved health quality which in turn is expected to drive the global market for CRISPR technology. Patient migration is further expected to be a major factor responsible for the global CRISPR technology market to propel. Moving forward, robust demand for CRISPR technology in agriculture industry are further estimated to create new necessities and augment the market of growth over the forecast period of 2018-2026.

Drugs and Therapeutic Discovery segment is estimated to witness significant growth

The CRISPR technology market has been segmented based on types into gRNA, proteins, vectors, library, designing tools, control kits, plasmids and others. Based on application, the CRISPR technology market has been segmented as agricultural biotech, biological research, industrial biotech and drugs and therapeutic discovery. Drugs and therapeutic discovery segment is estimated to witness significant growth during the projection period owing to the rise in the birth rate with inborn gene defects and genetic diseases. Gene related diseases are expected to increase at any stage of life owing to the increased exposure of human skins and organs with chemical and radioactive components. In addition, the rise in public and private spending in healthcare industry to develop and outsource gene therapeutic procedures to improve the standard of living of the global populations are further expected to be a prime cause responsible for the global CRISPR Technology market to propel during the forecast period.

North America holds the largest market share by region

The global CRISPR technology market has been geographically segmented into Asia-Pacific, Europe, North America, Latin America, the Middle East and Africa region. In addition to this, North America region holds the largest market share. The reason may be attributed to the supportive public expenditure in healthcare to improve the therapeutics of gene disorder diseases coupled with the presence of greater numbers of manufacturers and exporters of CRISPR technology across the globe. Asia-Pacific CRISPR technology market is estimated to be another major contributor towards the increasing demand of CRISPR technology. Rapid population growth in countries such as China, India, Bangladesh and others coupled with the increased government spending towards increasing agricultural productivity are the factors expected for the Asia-Pacific CRISPR technology market to propel during the forecast period. Rising applications of CRISPR technology in industrial biotech sector is expected to boost the Europe for CRISPR technology market. These reasons are expected to positively influence the market growth during the forecasted period.

Major Players in CRISPR Technology Market

Some of the key players in the global CRISPR technology market include Applied Stemcell Inc., Dharmacon Inc., Diacarta, Inc, Edigene Inc., Fenedata AG., Genescript, Mirus Bio LLC, Origene Technologies Inc., Oxford Genetics Ltd., Rockland Immunochemicals Inc., System Biosciences LLC and Thermo Fisher Scientific Inc.

The global CRISPR technology market has been segmented into:

Global CRISPR Technology Market: By Types

·         gRNA

·         Proteins

·         Vectors

·         Library

·         Designing Tools

·         Control Kits

·         Plasmids

·         Others

Global CRISPR Technology Market: By Application

·         Agricultural Biotech

·         Biological Research

·         Industrial Biotech

·         Drugs and Therapeutic Discovery

Global CRISPR Technology Market: By Geography

·         North America

o    U.S.

o    Canada

o    Mexico

·         Europe

o    U.K.

o    France

o    Germany

o    Italy

o    Rest of Europe

·         Asia Pacific

o    India

o    China

o    Japan

o    Rest of Asia Pacific

·         Middle East and Africa

o    South Africa

o    Rest of Middle East and Africa

·         Latin America

o    Brazil

o    Rest of Latin America